<p>Capital Ideas Media publisher Mark Bunting talks to Aras Azadian, the CEO of newly-public Avicanna (TSX:AVCN), a science-based, low-cost cannabis company with an impressive list of partners from Johnson & Johnson to Princess Margaret Hospital.</p>

Capital Ideas Media publisher Mark Bunting talks to Aras Azadian, the CEO of newly-public Avicanna (TSX:AVCN), a science-based, low-cost cannabis company with an impressive list of partners from Johnson & Johnson to Princess Margaret Hospital.

<p>Capital Ideas Media publisher Mark Bunting talks to Aras Azadian, the CEO of newly-public Avicanna (TSX:AVCN), a science-based, low-cost cannabis company with an impressive list of partners from Johnson &amp; Johnson to Princess Margaret Hospital.</p>

Episode 042 - Aras Azadian, Co-Founder, CEO, Chairman, Avicanna

Hosted by Capital Ideas Media Publisher Mark Bunting, this show provides investment ideas to do-it-yourself investors by giving them access to the chief executives of innovative growth companies.

Share Episode 042 - Aras Azadian, Co-Founder, CEO, Chairman, Avicanna

Sign up to save your podcasts

Episode 042 - Aras Azadian, Co-Founder, CEO, Chairman, Avicanna

Episode 042 - Aras Azadian, Co-Founder, CEO, Chairman, Avicanna